Clin2
NCT06701539Possibly a fitNot yet recruiting

Liposomal bupivacaine for pain after brain tumor surgery

Liposome Bupivacaine

Part of Brain & nervous system, Pain clinical trials.

This trial tests a long-acting numbing medicine (liposomal bupivacaine) injected at the surgery site to reduce pain after brain tumor removal. It aims to improve pain control and reduce the need for other painkillers.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
106 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are scheduled for brain surgery to remove a tumor through a specific opening in the skull (frontotemporal, temporal base, or temporal occipital approach).
  • You are in good general health (classified as ASA I to III).
  • You do not have severe chronic pain or long-term use of painkillers.
  • You are not allergic to the study drug or similar medicines.
  • You do not have serious heart, lung, liver, or kidney problems.
  • You are not pregnant or breastfeeding, and you do not have a history of drug abuse.
  • Your body mass index (BMI) is below 35.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07667439Not yet recruiting
Numbing medicine for pain after upper abdominal surgery

This trial tests a long-lasting numbing medicine injected near the back muscles to reduce pain after open surgery on the liver, stomach, or pancreas. It may help you need fewer painkillers and recover more comfortably.

Hangzhou
NCT07245290Not yet recruiting· Early Phase 1
Numbing medicine for pain relief after brain surgery

This trial tests whether injecting a long-acting numbing medicine near the surgery site can reduce pain after brain surgery for nerve compression. If it works, patients may have less pain and need fewer painkillers after the procedure.

NCT07432711Recruiting
Liposomal bupivacaine for pain after lung surgery

This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.

Beijing, Beijing Municipality
NCT07458295Recruiting
Liposomal bupivacaine for pain after gynecologic cancer surgery

This trial tests whether a long-acting numbing medication (liposomal bupivacaine) injected into the abdominal wall can reduce pain after laparoscopic surgery for gynecologic cancer. If effective, it may help patients recover with less discomfort and fewer painkillers.

Beijing, Beijing Municipality
NCT07458256Recruiting
Liposomal bupivacaine for pain after laparoscopic surgery

This trial tests a long-acting painkiller injected during surgery to see if it reduces pain after keyhole (laparoscopic) procedures like gallbladder removal, hernia repair, or appendix removal. It may help you need fewer opioids and recover more comfortably.

Beijing, Beijing Municipality
NCT07049094Recruiting· Phase 4
Scalp nerve block for pain after brain surgery

This trial tests if a long-lasting numbing medicine (bupivacaine liposomes) injected into scalp nerves can reduce pain after brain surgery. It may help you need less pain medicine and feel better after your operation.

Hangzhou, Zhejiang

Hear when a new Liposome Bupivacaine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.